Relationship between white matter hyperintensity and atherogenic index of plasma in migraine

Gulhan Sarıcam1, Fahrettin Ege2, Memet Aslanyavrusu3

  • 1Department of Neurology Clinic, Pursaklar State Hospital, Ankara, Turkey.

PubMed
Abstract

Insights

White matter hyperintensities (WMH) are linked to higher atherogenic index of plasma (AIP) in migraine patients. Increased AIP is a significant marker for identifying WMH, offering a cost-effective diagnostic tool.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Medical Diagnostics

Background:

  • White matter hyperintensities (WMH) are frequently observed in migraine patients, yet their underlying causes are not fully understood.
  • Migraine is associated with an increased prevalence of WMH compared to the general population, highlighting a potential link to cerebrovascular health.

Purpose of the Study:

  • To investigate the association between the atherogenic index of plasma (AIP), a marker of vascular risk, and the presence of WMH in individuals with migraine.
  • To determine if AIP can serve as a predictive marker for WMH in migraineurs.

Main Methods:

  • The study included 274 patients diagnosed with migraine according to the International Classification of Headache Disorders (ICHD-III).
  • Two-state logistic regression analysis and cubic spline curves were employed to assess the relationship between WMH and AIP, examining linearity and significance.

Main Results:

  • Patients with WMH exhibited significantly higher prevalence of aura, age, disease duration, AIP, triglycerides (TG), and body mass index (BMI).
  • A two-state regression analysis revealed a significant linear relationship between elevated AIP (OR: 7.101) and WMH in migraine patients.
  • Increased TG levels also showed a significant association with WMH (OR: 1.016).

Conclusions:

  • A positive correlation was established between WMH and AIP values in the migraine patient cohort.
  • AIP was identified as a statistically significant discriminator for WMH, suggesting its utility as a cost-effective marker for WMH detection in migraine patients.